Search research articles
Contact Us
Filters
Showing results (61-70 of 64) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 64 results.
Cell Reports
|
May 18, 2017
A Murine Intestinal Intraepithelial NKp46-Negative Innate Lymphoid Cell Population Characterized by Group 1 Properties
Aline Van Acker, Konrad Gronke, Aindrila Biswas, et al.
The Journal of Experimental Medicine
|
March 27, 2013
Specific Notch receptor-ligand interactions control human TCR-αβ/γδ development by inducing differential Notch signal strength
Inge Van de Walle, Els Waegemans, Jelle De Medts, et al.
Nature Communications
|
April 7, 2016
GATA3 induces human T-cell commitment by restraining Notch activity and repressing NK-cell fate
Inge Van de Walle, Anne-Catherine Dolens, Kaat Durinck, et al.
The Journal of Antimicrobial Chemotherapy
|
January 4, 2011
Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment
Linos Vandekerckhove, Chris Verhofstede, Els Demecheleer, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 64) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 64 results.
Cell Reports
|
May 18, 2017
A Murine Intestinal Intraepithelial NKp46-Negative Innate Lymphoid Cell Population Characterized by Group 1 Properties
Aline Van Acker, Konrad Gronke, Aindrila Biswas, et al.
The Journal of Experimental Medicine
|
March 27, 2013
Specific Notch receptor-ligand interactions control human TCR-αβ/γδ development by inducing differential Notch signal strength
Inge Van de Walle, Els Waegemans, Jelle De Medts, et al.
Nature Communications
|
April 7, 2016
GATA3 induces human T-cell commitment by restraining Notch activity and repressing NK-cell fate
Inge Van de Walle, Anne-Catherine Dolens, Kaat Durinck, et al.
The Journal of Antimicrobial Chemotherapy
|
January 4, 2011
Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment
Linos Vandekerckhove, Chris Verhofstede, Els Demecheleer, et al.
Page
of 7